Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell

NCT01913119 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01913119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01913119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell
Lead sponsor
Samsung Medical Center
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2013
Completion date
July 31, 2013
Enrollment
16 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

histologically proven extranodal nktcell lymphoma